Social inequalities in survival among women with breast cancer in southeastern Brazil: a retrospective cohort study

Read full text
Authors: Raphael Manhães Pessanha, Wesley Rocha Grippa, L F Pinto Neto, Larissa Soares Dell’Antonio, Cristiano Soares da Silva Dell’Antonio, Luís Carlos Lopes-Júnior
Cited by: 1

Abstract

Background: Breast cancer (BC) remains the most common malignancy among women worldwide and a leading cause of cancer-related death, particularly in low- and middle-income countries. Social inequalities are known to influence access to diagnosis, treatment, and survival outcomes. However, evidence on these disparities in middle-income settings, such as Brazil, remains limited. Here, we investigated the association between sociodemographic factors and survival among women diagnosed with BC treated at all hospitals that comprise the Oncology Care Network of a state in southeastern Brazil. Methods: We conducted a hospital-based retrospective cohort study using data from the Hospital Cancer Registries and the Mortality Information System of Espírito Santo, Brazil. The cohort included 12,096 women diagnosed with BC. Cases were categorized as death from BC, death from other causes, or survival at 5 years. Five-year survival was estimated using the Kaplan-Meier method and compared using the log-rank test. A Cox proportional hazards model for cause-specific mortality was applied for multivariate analysis. Results: Among the cohort, 8,184 (67.66%) women survived until the end of follow-up, 2,947 (24.28%) died from BC, and 975 (8.06%) died from other causes. The overall cause-specific survival at 5 years was 82%. Multivariate analysis revealed that race was an independent risk factor for BC-specific mortality: Black women had a 60% higher risk of death compared with White women [hazard ratio (HR) =1.601; 95% confidence interval (CI): 1.303-1.967; P

Fields of Study & Subjects

Global Cancer Incidence and Screening Women's cancer prevention and management Cancer Risks and Factors

Publication details

Journal / source
Translational Breast Cancer Research
Publisher
AME Publishing Company
Volume
7
Pages
4–4
Publication date
1 January 2026
Language
EN